RT Journal Article
SR Electronic
T1 UV Decontamination of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.25.20043489
DO 10.1101/2020.03.25.20043489
A1 Weaver, Davis T.
A1 McElvany, Benjamin D.
A1 Gopalakrishnan, Vishhvaan
A1 Card, Kyle J.
A1 Crozier, Dena
A1 Dhawan, Andrew
A1 Dinh, Mina N.
A1 Dolson, Emily
A1 Farrokhian, Nathan
A1 Hitomi, Masahiro
A1 Ho, Emily
A1 Jagdish, Tanush
A1 King, Eshan S.
A1 Krishnan, Nikhil
A1 Kuzmin, Gleb
A1 Li, Ju
A1 Maltas, Jeff
A1 Mo, Jinhan
A1 Pelesko, Julia
A1 Scarborough, Jessica A.
A1 Sedor, Geoff
A1 Tian, Enze
A1 An, Gary C.
A1 Diehl, Sean
A1 Scott, Jacob G.
YR 2020
UL http://medrxiv.org/content/early/2020/10/19/2020.03.25.20043489.abstract
AB Personal protective equipment (PPE) is crucially important to the safety of both patients and medical personnel, particularly in the event of an infectious pandemic. As the incidence of Coronavirus Disease 2019 (COVID-19) increases exponentially in the United States and many parts of the world, healthcare provider demand for these necessities is currently outpacing supply. In the midst of the current pandemic, there has been a concerted effort to identify viable ways to conserve PPE, including decontamination after use. In this study, we outline a procedure by which PPE may be decontaminated using ultraviolet (UV) radiation in biosafety cabinets (BSCs), a common element of many academic, public health, and hospital laboratories. According to the literature, effective decontamination of N95 respirator masks or surgical masks requires UV-C doses of greater than 1 Jcm−2, which was achieved after 4.3 hours per side when placing the N95 at the bottom of the BSCs tested in this study. We then demonstrated complete inactivation of the human coronavirus NL63 on N95 mask material after 15 minutes of UV-C exposure at 61 cm (232 μW cm−2). Our results provide support to healthcare organizations looking for methods to extend their reserves of PPE.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWhile this specific project was not directly funded by any body, we would like to thank our funders in the form of the National Institutes of Health and the American Cancer Society and the Taussig Cancer and Lerner Research Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used to produce this manuscript are available on github. https://github.com/TheoryDivision/covid19_biosafety_cabinet